Pharmacotherapy: the Journal of Human Pharmacology and Drug Therapy
-
Publication Venue For
- Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper.. 40:368-371. 2020
- Predictors of Warfarin Time in Therapeutic Range after Continuous-Flow Left Ventricular Assist Device.. 39:1030-1035. 2019
- Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.. 38:406-416. 2018
- Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.. 37:700-711. 2017
- Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.. 37:429-437. 2017
- Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure.. 36:1210-1216. 2016
- Influence of Successful Chronic Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir on Warfarin Dosing Requirements in Four Veterans.. 36:1173-1179. 2016
- Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice.. 36:e40-e49. 2016
- The Role of Statin Therapy in Hemorrhagic Stroke.. 35:1152-1163. 2015
- Impact of liposomal bupivacaine administration on postoperative pain in patients undergoing total knee replacement.. 35:477-481. 2015
- Collaborative drug therapy management and comprehensive medication management-2015.. 35:e39-e50. 2015
- Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis.. 34:e120-e127. 2014
- Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.. 34:670-676. 2014
- Cholinesterase inhibitors and Pisa syndrome: a pharmacovigilance study.. 34:272-278. 2014
- Improving care transitions: current practice and future opportunities for pharmacists.. 32:e326-e337. 2012
- Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options.. 32:890-901. 2012
- Effects of tobacco smoking and nicotine on cancer treatment.. 32:920-931. 2012
- Antimicrobial stewardship: a matter of process or outcome?. 32:688-706. 2012
- Effect of colistin on phospholipid-based activated partial thromboplastin time clotting assay results in patients receiving concomitant heparin therapy.. 31:277-279. 2011
- Nebulizer delivery of micafungin aerosols.. 31:52-57. 2011
- Alternative therapies for Clostridium difficile infections.. 30:1266-1278. 2010
- Patterns of antihypertensive treatment in patients with acute severe hypertension from a nonneurologic cause: Studying the Treatment of Acute Hypertension (STAT) registry.. 30:1087-1096. 2010
- Management of drug and food interactions with azole antifungal agents in transplant recipients.. 30:842-854. 2010
- Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists.. 30:562-584. 2010
- Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.. 30:539. 2010
- Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative.. 29:631-638. 2009
- Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.. 29:593-607. 2009
- Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.. 29:503-510. 2009
- Recommendations for training and certification for pharmacists practicing, mentoring, and educating in infectious diseases pharmacotherapy.. 29:482-488. 2009